
Marksans Pharma Ltd
NSE:MARKSANS

During the last 3 months Marksans Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nse/marksans/vs/indx/bsesn">open performance analysis).
The last transaction was made on
Aug 18, 2023
by
Arvind Singh
(Chairman & Managing Director)
, who
bought
347.3k INR
worth of MARKSANS shares.
During the last 3 months Marksans Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nse/marksans/vs/indx/bsesn">open performance analysis).
The last transaction was made on
Aug 18, 2023
by
Arvind Singh
(Chairman & Managing Director)
, who
bought
347.3k INR
worth of MARKSANS shares.
Marksans Pharma Ltd
Glance View
Marksans Pharma Ltd. is a prominent player in the global pharmaceutical landscape, with its roots deeply embedded in the meticulous world of drug formulation and manufacturing. The company weaves its narrative through a robust portfolio that spans various therapeutic segments, including pain management, oncology, cardiovascular health, and anti-diabetic medications. By navigating the complexities of regulated markets such as the United States, the United Kingdom, and Australia, Marksans has engineered a business model that emphasizes quality, compliance, and innovation. This framework allows the company not only to design and develop a diverse array of generic pharmaceutical products but also to efficiently cater to a global clientele through its cost-effective yet high-quality manufacturing processes. Central to Marksans' success is its strategic integration of research and development with flexible manufacturing capabilities, housed in state-of-the-art facilities across Goa and India. These facilities, certified by leading international regulatory bodies, enable Marksans to maintain a competitive edge in both product delivery and diversification. By leveraging strategic partnerships and continuously expanding its product portfolio, it thrives in the dynamic pharmaceutical market. Revenue generation flows seamlessly through its vertically integrated operations, which streamline the journey from drug conception to distribution. Through these concerted efforts, Marksans not only bolsters its financial standing but also contributes significantly to the broader field of global healthcare, aligning economic performance with a commitment to health and well-being.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.